On February 11, 2025 Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, reported that Michael King, Chief Executive Officer, will present data at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference (Press release, Oqory, FEB 11, 2025, View Source [SID1234650188]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follows:

Date: Wednesday, February 12, 2025

Time: 12:40 PM ET

Webcast link for conference participants:
View Source